Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases

LOS ANGELES, Aug. 7 /PRNewswire-USNewswire/ -- A new drug delivery system that uses a tiny silicone cup filled with any drug and sealed to the outer surface (episclera) of the eyeball may offer a more effective method for the sustained delivery of medicines for retinal and vitreous disea...

Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial

SOUTH SAN FRANCISCO, Calif., July 9 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that R788 (fostamatinib disodium) produced significant clinical improvement in rheumatoid arthritis (RA) patients in the recently completed TASKi2 Phase 2b clinical trial of ...

Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia

PALO ALTO, Calif., June 15 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals' (Nasdaq: JAZZ ) sodium oxybate (JZP-6) demonstrated statistically significant and clinically meaningful improvement in pain and the core symptoms associated with fibromyalgia, according to Phase III data presented last we...

FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSK's Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight

ROCKVILLE, Md. , June 8 /PRNewswire-FirstCall/ -- Attached is a press release issued yesterday by GlaxoSmithKline (GSK), regarding new Phase 2 data for Syncria(R) (albiglutide) presented at the American Diabetes Association 69th Scientific Sessions in New Orleans. (Logo: http://www.newsco...

Heparin Use Prior to Endoscopic Vein Harvest Improves Graft Patency in Off-Pump Coronary Artery Bypass Patients

Pre-heparinization Limits Clot Retention and Decreases Residual Clot Volume SAN FRANCISCO, June 8 /PRNewswire/ -- MAQUET Cardiovascular LLC announced today that data presented at the annual meeting of the International Society for Minimally Invasive Cardiothoracic Surgery show that administ...

Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight

LONDON, RESEARCH TRIANGLE PARK, N.C., and NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria(R) (albiglutide) significantly redu...

Back to Normal: Surgery Improves Outcomes for Spine Patients

New study finds patients who opt for surgery have decreased pain, increased function ROSEMONT, Ill., June 1 /PRNewswire-USNewswire/ -- People with the spine disease called degenerative spondylolisthesis * -- who choose surgical treatment -- experience substantially greater relief f...

New Research Shows Nutrition 21's Chromium Histidinate Improves Markers for Mood and Carbohydrate Cravings

U.S.D.A. Animal Studies: Chromium Picolinate and Chromium Histidinate Down-regulate Gene in Brain that Precedes Alzheimer's Disease Additional Studies Continue to Demonstrate Safety and Efficacy of Nutrition 21's Chromax Chromium Picolinate PURCHASE, N.Y., May 14 /PRNewswire-FirstCall/ -...

New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure

AZTEC Trial First to Examine AZOR Using 24-Hour Ambulatory BP Measures PARSIPPANY, N.J., May 8 /PRNewswire/ -- Daiichi Sankyo, Inc. announced today that data presented at the American Society of Hypertension, Inc. (ASH) Twenty-Fourth Annual Scientific Meeting and Exposition (ASH 2009) in San ...

Program Improves Language Skills in Deaf, Hard of Hearing

CINCINNATI, May 5 /PRNewswire-USNewswire/ -- Children enrolled before they are six months old in a home-based program that teaches language skills to the deaf or hard of hearing are not only able to achieve appropriate language skills but also to maintain them over time, according to a new study. ...

Brain Training Improves Memory and Attention and the Effects Last

CHICAGO, May 1 /PRNewswire/ -- Older adults can improve memory and attention by training on computerized brain exercises according to study data presented today at the annual meeting of the American Geriatrics Society in Chicago. Elizabeth Zelinski, PhD, lead investigator on the study and a profes...

Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies

SAN MARINO, Calif., Nov. 20 /PRNewswire/ -- Epeius Biotechnologies announced today the results of Phase I/II and II studies of Rexin-G in chemotherapy-resistant metastatic soft tissue sarcoma and osteosarcoma, as presented by Dr. Sant P. Chawla, principal investigator, at the CTOS 14th annual meet...

Vascular Surgeons Agree: Case Rehearsal Improves Outcomes

CLEVELAND, Ohio and LOD, Israel, November 12 /PRNewswire/ -- Surgeons at the University of Rochester Medical Center, NY indicated that patient-specific CTA data can be converted to an endovascular simulator (ANGIO Mentor(TM), Simbionix US) with high face validity. The surgeons "strongly agreed...

Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder

First Clinical Study of Paliperidone ER in this Under-Studied Condition SAN DIEGO, Nov. 1 /PRNewswire/ -- Patients with schizoaffective disorder receiving paliperidone extended release tablets (paliperidone ER) for six weeks showed a significant improvement in their symptoms, according to a ne...

Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution

BOSTON, Oct. 15 /PRNewswire-FirstCall/ -- Perceptive Informatics, one of the industry's leading eClinical technology providers and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL ), announced today that it has enhanced its TrialWorks(R) solution, a specialized Clinical Trial M...

TOZAL(R) Nutritional Supplement Improves Vision in Common Form of Macular Degeneration

- Multicenter study finds unique combination of micronutrients superior to current 'AREDS' standard of care; Results supported by new omega-3 study - HOUSTON, Sept. 10 /PRNewswire/ -- A landmark study at five university-based research centers found that TOZAL(R), a patented combination of anti...

96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS

PALO ALTO, Calif., Sept. 1 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today its new filtration plate for sample preparation. Captiva(TM) NDLipids is a simple to use, non-drip 96-well plate specially designed to remove phospholipids including lysophosphatidylcholines, fro...

American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation

MONTPELLIER, France, September 1 /PRNewswire/ -- The ERATO study published today in the American Heart Journal demonstrated, for the first time in patients with permanent atrial fibrillation, that dronedarone (Multaq(R)) significantly reduces mean 24 hour ventricular rate, on top of other rate...

'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss

Findings in rats show promise for 'buying time' in victims of lethal hemorrhage SEATTLE, July 1 /PRNewswire/ -- For the first time, researchers have demonstrated that the administration of minute amounts of inhaled or intravenous hydrogen sulfide, or H2S -- the ...

Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia

Study Meets Primary Endpoint, with Positive Effect Sustained Through Duration of 4-Week Study ROCKVILLE, Md., June 26 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ) (Vanda) today announced positive top-line results from a Phase III trial showing ...

Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome

New Data Highlights the Need for Testosterone Screening in At-Risk Hypogonadal Men BEDMINSTER, N.J., June 17 /PRNewswire/ -- New data from a 12-month, international, multi-center study showed that treatment for low testosterone with Tostran(R), a topical, metered ...

Abbott's Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes

TriLipix in Combination with CRESTOR (rosuvastatin calcium) Demonstrates Similar Lipid Effects in Patients with Diabetes and Overall Study Population SAN FRANCISCO, June 7 /PRNewswire-FirstCall/ -- New data from a sub-group analysis of patients with mixed dyslip...

New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma

- Data From Phase 3 Study Presented at ASCO - COLLEGEVILLE, Pa., May 31 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), today announced results of a three-arm phase 3 clinical trial that show patients with relapsed and/or refractory mantle cell ...

CPR Data Debriefing by Hospital Responders Improves CPR Performance and Increases Initial Survival Rate Following Cardiac Arrest

Study published in Archives of Internal Medicine supports use of Q-CPR(TM) technology to improve CPR quality ANDOVER, Mass., May 26 /PRNewswire-FirstCall/ -- Royal Philips Electronics (NYSE: PHG , AEX: PHI) today announced the results of a study confirming the benefit of usin...

CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation

New Data Underscore the Utility of CAPHOSOL in Treating Oral Mucositis PRINCETON, N.J., May 21 /PRNewswire/ -- New data show that CAPHOSOL(R) (http://www.caphosol.com ), an advanced electrolyte solution, relieves painful oral mucositis (OM) and improves quality of life for cancer patients un...

Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study

- Trial Results Confirm Efficacy for Population Most Affected by Disease - WAYNE, N.J. and EMERYVILLE, Calif., May 16 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that Nexavar(R) (sorafenib) tablets significantl...

AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients

-Specific biomarkers for molecular tumor grade and endocrine benefit offer better prediction of individual patient outcome- SAN DIEGO, May 13 /PRNewswire/ -- AviaraDx, Inc. today announced the publication of an article describing the discovery, development and validation of a new mol...

Ceremed's OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows

LOS ANGELES, May 13 /PRNewswire/ -- New soluble polymer material designed to stop bone bleeding in surgery improves bone fusion and healing, according to a new animal study just published in the Annals of Thoracic Surgery (ATS). The findings come on the heels of recently published research sho...

Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents

Phase III Data Presented at American Psychiatric Association Annual Meeting WASHINGTON, May 7 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX ) announced today that study results show Lexapro (escitalopram oxalate) significantly improved symptoms of depression as compared to plac...

Gene Therapy Improves Vision in Patients with Congenital Retinal Disease

Patients' Vision Improved from Detecting Hand Movements to Reading Lines on Eye Chart PHILADELPHIA, April 27 /PRNewswire-USNewswire/ -- In a clinical trial at The Children's Hospital of Philadelphia, researchers from The University of Pennsylvania have used gene therapy to safely restore...

SuperGen's DNA Methyltransferase Inhibitor, S-110, Improves In Vivo Efficacy Profile of Decitabine

Restored sensitivity to cisplatin observed in ovarian carcinoma xenografts DUBLIN, Calif., April 14 /PRNewswire-FirstCall/ -- SuperGen Inc. (Nasdaq: SUPG ), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematologi...

Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder

- Clinical evidence for unique Ranexa(R) mechanism of action - CHICAGO, March 31 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX ) announced today that ranolazine significantly (p<0.001) shortened the QT interval of patients with a hereditary form of long QT syndrome called...

Tailored Clopidogrel Dosing Improves PCI Outcomes

Blood test monitors each patient's response to anti-clotting drug CHICAGO, March 29 /PRNewswire/ -- Using a simple blood test to individualize the loading dose of a medication that prevents blood clotting significantly reduces the risk of major cardiovascular complications after percutaneou...

Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting

Company Also Announces Receipt of Fast Track Designation from FDA, Favorable Scientific Advice from EMEA and Phase 3 Plans for the Non-Small Cell Lung Cancer Monotherapy Indication SANTA MONICA, Calif., Feb. 26 /PRNewswire/ -- Dr. Giuseppe Giaccone, Chief of the Medical Onco...

New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies

- Human Genome Sciences' ABthrax(TM) shows lifesaving potential - - HGS on track to deliver 20,000 doses to Strategic National Stockpile beginning in 2008 - ROCKVILLE, Md., Dec. 18 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) today annou...

TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil

Data from Pivotal Study Show Bendamustine Produced a Significant Increase in Overall Response Rate and Progression Free Survival FRAZER, Pa., Dec. 10 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that in a pivotal study of treatment-naive patients with chronic ...

New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer

- First Study to Demonstrate Survival Benefit with ERBITUX in Patients with Colorectal Cancer Refractory to All Approved Chemotherapies - NEW YORK, Nov. 14 /PRNewswire-FirstCall/ -- ImClone Systems Incorporated (Nasdaq: IMCL ) and Bristol-Myers Squibb Company (NYSE: BMY ) announced today r...

First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival

-- Major study of more than 2,100 patients with hip fracture shows significant 35% reduction in subsequent osteoporotic fractures with Reclast -- Results published in The New England Journal of Medicine show significant 28% reduction in overall mortality seen in study patients ...

Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study

BROOMFIELD, Colo., Aug. 29 /PRNewswire/ -- Accera, Inc. announced today that recent data from a Phase II study of its lead compound Ketasyn(TM) (AC- 1202) in age-associated memory impairment (AAMI) showed that Ketasyn has a positive and clinically meaningful effect on memory in older adults. ...

Once Daily, Extended-Release Ropinirole Improves Parkinson's Symptoms in Patients not Optimally Controlled With Levodopa

'Off' Time Reduced By an Average of More Than Two Hours Per Day RESEARCH TRIANGLE PARK, N.C., April 02, 2007 /PRNewswire/ -- Adding the once daily, investigational medication REQUIP(R) (ropinirole HCl) XL 24-Hour(TM) Extended-Release Tablets to Parkinson's patients' existing levodopa (L-dopa) ther...